118 related articles for article (PubMed ID: 34126859)
1. Studying the ophthalmic toxicity potential of developed ketoconazole loaded nanoemulsion
Tavakoli M; Mahboobian MM; Nouri F; Mohammadi M
Toxicol Mech Methods; 2021 Oct; 31(8):572-580. PubMed ID: 34126859
[TBL] [Abstract][Full Text] [Related]
2. Ocular toxicity assessment of nanoemulsion in-situ gel formulation of fluconazole.
Samimi MS; Mahboobian MM; Mohammadi M
Hum Exp Toxicol; 2021 Dec; 40(12):2039-2047. PubMed ID: 34036827
[TBL] [Abstract][Full Text] [Related]
3. Investigating the ocular toxicity potential and therapeutic efficiency of
Talaei S; Mahboobian MM; Mohammadi M
Toxicol Res (Camb); 2020 Jul; 9(4):578-587. PubMed ID: 32905229
[TBL] [Abstract][Full Text] [Related]
4. Amelioration of ketoconazole in lipid nanoparticles for enhanced antifungal activity and bioavailability through oral administration for management of fungal infections.
Dudhipala N; Ay AA
Chem Phys Lipids; 2020 Oct; 232():104953. PubMed ID: 32814084
[TBL] [Abstract][Full Text] [Related]
5. Design and development of a novel pH triggered nanoemulsified in-situ ophthalmic gel of fluconazole: ex-vivo transcorneal permeation, corneal toxicity and irritation testing.
Pathak MK; Chhabra G; Pathak K
Drug Dev Ind Pharm; 2013 May; 39(5):780-90. PubMed ID: 22873799
[TBL] [Abstract][Full Text] [Related]
6. A potential in situ gel formulation loaded with novel fabricated poly(lactide-co-glycolide) nanoparticles for enhancing and sustaining the ophthalmic delivery of ketoconazole.
Ahmed TA; Aljaeid BM
Int J Nanomedicine; 2017; 12():1863-1875. PubMed ID: 28331311
[TBL] [Abstract][Full Text] [Related]
7. Colloidal lipid nanodispersion enriched hydrogel of antifungal agent for management of fungal infections: Comparative in-vitro, ex-vivo and in-vivo evaluation for oral and topical application.
Dudhipala N; Ali Youssef AA; Banala N
Chem Phys Lipids; 2020 Nov; 233():104981. PubMed ID: 33031802
[TBL] [Abstract][Full Text] [Related]
8. Development of loteprednol etabonate-loaded cationic nanoemulsified in-situ ophthalmic gel for sustained delivery and enhanced ocular bioavailability.
Patel N; Nakrani H; Raval M; Sheth N
Drug Deliv; 2016 Nov; 23(9):3712-3723. PubMed ID: 27689408
[TBL] [Abstract][Full Text] [Related]
9. Development, Optimization, and Antifungal Assessment of Ocular Gel Loaded With Ketoconazole Cubic Liquid Crystalline Nanoparticles.
Elfaky MA; Sirwi A; Tolba HH; Shaik RA; Selmi NM; Alattas AH; Albreki RS; Alshreef NM; Gad HA
J Pharm Sci; 2021 May; 110(5):2210-2220. PubMed ID: 33621518
[TBL] [Abstract][Full Text] [Related]
10. Improvement in Ocular Bioavailability and Prolonged Delivery of Tobramycin Sulfate Following Topical Ophthalmic Administration of Drug-Loaded Mucoadhesive Microparticles Incorporated in Thermosensitive In Situ Gel.
Khan S; Warade S; Singhavi DJ
J Ocul Pharmacol Ther; 2018 Apr; 34(3):287-297. PubMed ID: 29211593
[TBL] [Abstract][Full Text] [Related]
11. Nanoemulsion gel-based topical delivery of an antifungal drug: in vitro activity and in vivo evaluation.
Hussain A; Samad A; Singh SK; Ahsan MN; Haque MW; Faruk A; Ahmed FJ
Drug Deliv; 2016; 23(2):642-47. PubMed ID: 25013957
[TBL] [Abstract][Full Text] [Related]
12. Novel hydrogel-based ocular drug delivery system for the treatment of conjunctivitis.
Deepthi S; Jose J
Int Ophthalmol; 2019 Jun; 39(6):1355-1366. PubMed ID: 29922978
[TBL] [Abstract][Full Text] [Related]
13. The Antifungal and Ocular Permeation of Ketoconazole from Ophthalmic Formulations Containing Trans-Ethosomes Nanoparticles.
Ahmed TA; Alzahrani MM; Sirwi A; Alhakamy NA
Pharmaceutics; 2021 Jan; 13(2):. PubMed ID: 33498849
[TBL] [Abstract][Full Text] [Related]
14. Formulation and development of ophthalmic in situ gel for the treatment ocular inflammation and infection using application of quality by design concept.
Patel N; Thakkar V; Metalia V; Baldaniya L; Gandhi T; Gohel M
Drug Dev Ind Pharm; 2016 Sep; 42(9):1406-23. PubMed ID: 26716613
[TBL] [Abstract][Full Text] [Related]
15. Ocular tolerance of sertaconazole gel.
Romero A; Grau MT; Villamayor F; Zapatero J; Mayordomo L; Tortajada A; Sacristán A; Ortiz JA
Mycoses; 1996; 39(1-2):57-60. PubMed ID: 8786760
[TBL] [Abstract][Full Text] [Related]
16. Studying the influence of formulation and process variables on Vancomycin-loaded polymeric nanoparticles as potential carrier for enhanced ophthalmic delivery.
Yousry C; Elkheshen SA; El-Laithy HM; Essam T; Fahmy RH
Eur J Pharm Sci; 2017 Mar; 100():142-154. PubMed ID: 28089661
[TBL] [Abstract][Full Text] [Related]
17. Development of a Luliconazole Nanoemulsion as a Prospective Ophthalmic Delivery System for the Treatment of Fungal Keratitis: In Vitro and In Vivo Evaluation.
Yang J; Liang Z; Lu P; Song F; Zhang Z; Zhou T; Li J; Zhang J
Pharmaceutics; 2022 Sep; 14(10):. PubMed ID: 36297487
[TBL] [Abstract][Full Text] [Related]
18. A supramolecular thermosensitive gel of ketoconazole for ocular applications: In silico, in vitro, and ex vivo studies.
Chaudhari P; Naik R; Sruthi Mallela L; Roy S; Birangal S; Ghate V; Balladka Kunhanna S; Lewis SA
Int J Pharm; 2022 Feb; 613():121409. PubMed ID: 34952148
[TBL] [Abstract][Full Text] [Related]
19. Effect of different molecular weight PLGA on flurbiprofen nanoparticles: formulation, characterization, cytotoxicity, and
Öztürk AA; Yenilmez E; Şenel B; Kıyan HT; Güven UM
Drug Dev Ind Pharm; 2020 Apr; 46(4):682-695. PubMed ID: 32281428
[No Abstract] [Full Text] [Related]
20. Terminalia arjuna gum/alginate in situ gel system with prolonged retention time for ophthalmic drug delivery.
Noreen S; Ghumman SA; Batool F; Ijaz B; Basharat M; Noureen S; Kausar T; Iqbal S
Int J Biol Macromol; 2020 Jun; 152():1056-1067. PubMed ID: 31751751
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
